Critique of the analysis of the time course for the antimigraine effect of ubrogepant 50 mg. Clinical relevance versus statistical significance

Peer Tfelt-Hansen; Anika Hüsing; Hans-Christoph Diener

doi:10.1177/03331024211014625

Critique of the analysis of the time course for the antimigraine effect of ubrogepant 50 mg. Clinical relevance versus statistical significance

Peer Tfelt-Hansen, Anika Hüsing, Hans-Christoph Diener

Neurology, Department of

Original language	English
Journal	Cephalalgia : an international journal of headache
Volume	41
Issue number	11-12
Pages (from-to)	1276-1278
Number of pages	3
ISSN	0333-1024
DOIs	https://doi.org/10.1177/03331024211014625
Publication status	Published - Oct 2021

Access to Document

10.1177/03331024211014625

Cite this

Critique of the analysis of the time course for the antimigraine effect of ubrogepant 50 mg. Clinical relevance versus statistical significance. / Tfelt-Hansen, Peer; Hüsing, Anika; Diener, Hans-Christoph.

In: Cephalalgia : an international journal of headache, Vol. 41, No. 11-12, 10.2021, p. 1276-1278.

Research output: Contribution to journal › Journal article › Research › peer-review

@article{7ffe8b1165124996b87f813159d91cf2,

title = "Critique of the analysis of the time course for the antimigraine effect of ubrogepant 50 mg. Clinical relevance versus statistical significance",

author = "Peer Tfelt-Hansen and Anika H{\"u}sing and Hans-Christoph Diener",

year = "2021",

month = oct,

doi = "10.1177/03331024211014625",

language = "English",

volume = "41",

pages = "1276--1278",

journal = "Cephalalgia",

issn = "0333-1024",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "11-12",

}

TY - JOUR

T1 - Critique of the analysis of the time course for the antimigraine effect of ubrogepant 50 mg. Clinical relevance versus statistical significance

AU - Tfelt-Hansen, Peer

AU - Hüsing, Anika

AU - Diener, Hans-Christoph

PY - 2021/10

Y1 - 2021/10

UR - http://www.scopus.com/inward/record.url?scp=85105949971&partnerID=8YFLogxK

U2 - 10.1177/03331024211014625

DO - 10.1177/03331024211014625

M3 - Journal article

C2 - 33982622

VL - 41

SP - 1276

EP - 1278

JO - Cephalalgia

JF - Cephalalgia

SN - 0333-1024

IS - 11-12

ER -

Critique of the analysis of the time course for the antimigraine effect of ubrogepant 50 mg. Clinical relevance versus statistical significance

Access to Document

Other files and links

Cite this